Lamictal

Lamictal is a prescription medication primarily used to treat epilepsy and bipolar disorder. Manufactured by GlaxoSmithKline, a British multinational pharmaceutical company, Lamictal is produced in multiple countries to meet global demand. The brand was originally developed and marketed by GlaxoSmithKline in the United Kingdom. As of 2025, GlaxoSmithKline continues to be the ultimate owner of the Lamictal brand, with its headquarters in Brentford, England. There are no known local subsidiaries that own the brand; it is directly managed by the parent company.